Literature DB >> 9084854

Sentinel lymph node metastasis in experimental melanoma: relationships among primary tumor size, lymphatic vessel diameter and 99mTc-labeled human serum albumin clearance.

S D Nathanson1, P Anaya, M Avery, F W Hetzel, T Sarantou, S Havstad.   

Abstract

BACKGROUND: This study was designed to investigate the relationships among primary tumor size, lymphatic vessel diameters, the incidence of sentinel lymph node (SLN) metastasis and lymphatic clearance from murine footpad melanomas.
METHODS: Lymphatic clearance (LC) of [99mTc]HSA from the middle of the footpad of syngeneic C57BL/6 mice, with or without primary melanomas (sizes varying from 1 to 5 mm in anteroposterior diameter), was quantitated using a gamma scintillation detection system. Lymphatic vessel diameters (LD) were measured after injection of aniline blue dye into footpad tumors. The incidence of SLN, femoral lymph node (FLN), and lung metastases was recorded.
RESULTS: Metastasis to SLNs increased as tumor growth progressed (r = 0.976, p = 0.001), and there was a correlation between tumor size and both FLN (p = 0.041) and lung (p = 0.055) metastases. There was also a correlation between lymph node metastasis and LC (r = 0.83, p = 0.04) and LD (r = 0.84, p = 0.04).
CONCLUSIONS: These studies support the hypothesis that lymph flow and LD is increased in experimental murine melanomas and this relates to both primary tumor size and to lymphatic and hematogenous metastasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9084854     DOI: 10.1007/bf02303800

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  CCR7 regulates B16 murine melanoma cell tumorigenesis in skin.

Authors:  Lei Fang; Vivian C Lee; Emily Cha; Hong Zhang; Sam T Hwang
Journal:  J Leukoc Biol       Date:  2008-10       Impact factor: 4.962

Review 2.  Advances in lymphatic imaging and drug delivery.

Authors:  Satish K Nune; Padmaja Gunda; Bharat K Majeti; Praveen K Thallapally; M Laird Forrest
Journal:  Adv Drug Deliv Rev       Date:  2011-06-28       Impact factor: 17.873

3.  First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.

Authors:  I Van der Auwera; Y Cao; J C Tille; M S Pepper; D G Jackson; S B Fox; A L Harris; L Y Dirix; P B Vermeulen
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

4.  VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma.

Authors:  Li-Cheng Du; Xian-Cheng Chen; Dong Wang; Yan-Jun Wen; Chun-Ting Wang; Xue-Mei Wang; Bing Kan; Yu-Quan Wei; Xia Zhao
Journal:  Reprod Biol Endocrinol       Date:  2014-02-06       Impact factor: 5.211

Review 5.  Current and future lymphatic imaging modalities for tumor staging.

Authors:  Ghulam Murtaza; Kuo Gao; Tiegang Liu; Imran Tariq; Ashif Sajjad; Muhammad Rouf Akram; Meiying Niu; Guokai Liu; Zahid Mehmood; Guihua Tian
Journal:  Biomed Res Int       Date:  2014-03-16       Impact factor: 3.411

6.  Raman Nanotags-Guided Intraoperative Sentinel Lymph Nodes Precise Location with Minimal Invasion.

Authors:  Binge Deng; Yaohui Wang; Yifan Wu; Wenjin Yin; Jinsong Lu; Jian Ye
Journal:  Adv Sci (Weinh)       Date:  2021-11-05       Impact factor: 16.806

Review 7.  Lymphangiogenesis and cancer metastasis.

Authors:  Viviane Mumprecht; Michael Detmar
Journal:  J Cell Mol Med       Date:  2009-07-06       Impact factor: 5.310

8.  VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein.

Authors:  Xiaorong Qi; Licheng Du; Xiancheng Chen; Lijuan Chen; Tao Yi; Xiang Chen; Yanjun Wen; Yuquan Wei; Xia Zhao
Journal:  Int J Oncol       Date:  2016-05-17       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.